NCT03914963View on ClinicalTrials.gov

Efficacy of a Fibrin Sealant for the Prevention of Lymphocele After Lymphadenectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

February 1, 2012

Primary Completion Date

June 1, 2016

Study Completion Date

June 1, 2016

Conditions
Lymphocele
Interventions
BIOLOGICAL

Fibrin sealant hemipelvis

Following the manufacturer´s instructions, 5 ml of sealant was sprayed evenly across the entire surgical bed in only one hemipelvis (the treated hemipelvis) after pelvis bilateral lymphadenectomy.

BIOLOGICAL

Control hemipelvis

Contralateral hemipelvis not treated with fibrin sealant

All Listed Sponsors
lead

IBON JAUNARENA

OTHER

NCT03914963 - Efficacy of a Fibrin Sealant for the Prevention of Lymphocele After Lymphadenectomy | Biotech Hunter | Biotech Hunter